Impact of the age of diagnosis on the natural history of ulcerative colitis

Revista Espanola de Enfermedades Digestivas

Volumn 107, Issue 10, 2015, Pages 614-621

  Cúrdia Gonçalves, Tiago ^a   Dias de castro, Francisca ^a   Machado, Joao Firmino ^b   Moreira, Maria Joao ^a   Rosa, Bruno ^a   Cotter, José ^a,c,d  

^a Gastroenterology Department   (Portugal)

^b Departamento de Saúde Pública   (Portugal)

^c UNIVERSITY OF MINHO   (Portugal)

^d UNIVERSITY OF MINHO   (Portugal)

Author keywords

Age of diagnosis; Natural history; Onset; Ulcerative colitis

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; BIOLOGICAL PRODUCT; IMMUNOMODULATING AGENT; INFLIXIMAB; ISONIAZID; MERCAPTOPURINE; METHOTREXATE; STEROID; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; AGED; ARTHRITIS; ARTICLE; COLITIS; COLON RESECTION; DISEASE ACTIVITY; DISEASE COURSE; DISEASE EXACERBATION; DYSPLASIA; EPISCLERITIS; ERYTHEMA NODOSUM; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROCTITIS; PYODERMA GANGRENOSUM; RETROSPECTIVE STUDY; SMOKING HABIT; SPLENIC FLEXURE; THROMBOEMBOLISM; ULCERATIVE COLITIS; YOUNG ADULT; ADOLESCENT; CHILD; COLITIS, ULCERATIVE; ONSET AGE; PATHOLOGY; RISK FACTOR;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; CHILD; COLITIS, ULCERATIVE; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84951086618     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002; 347: 417-29. DOI: 10. 1056/NEJMra020831
2. Shivananda S, Lennard-Jones J, Logan R, et al. Incidence of inflammatory bowel disease across Europe: Is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996; 39: 690-7. DOI: 10. 1136/gut. 39. 5. 690
3. Tragnone A, Corrao G, Miglio F, et al. Incidence of inflammatory bowel disease in Italy: a nationwide population-based study. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Int J Epidemiol 1996; 25: 1044-52. DOI: 10. 1093/ije/25. 5. 1044
4. Azevedo LF, Magro F, Portela F, et al. Estimating the prevalence of inflammatory bowel disease in Portugal using a pharmaco-epidemiological approach. Pharmacoepidemiol Drug Saf 2010; 19: 499-510. DOI: 10. 1002/pds. 1930
5. Cosnes J, Gower-Rousseau C, Seksik P, et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011; 140: 1785-94. DOI: 10. 1053/j. gastro. 2011. 01.055
6. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142: 46-54 e42; quiz e30. DOI: 10. 1053/j. gastro. 2011. 10. 001
7. Ha CY, Newberry RD, Stone CD, et al. Patients with late-adult-onset ulcerative colitis have better outcomes than those with early onset disease. Clin Gastroenterol Hepatol 2010; 8: 682-7 e1. DOI: 10. 1016/j. cgh. 2010. 03. 022
8. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004; 126: 1504-17. DOI: 10. 1053/j. gastro. 2004. 01. 063
9. Carr N, Schofield PF. Inflammatory bowel disease in the older patient. Br J Surg 1982; 69: 223-5. DOI: 10. 1002/bjs. 1800690418
10. Zimmerman J, Gavish D, Rachmilewitz D. Early and late onset ulcerative colitis: Distinct clinical features. J Clin Gastroenterol 1985; 7: 492-8. DOI: 10. 1097/00004836-198512000-00010
11. Riegler G, Tartaglione MT, Carratu R, et al. Age-related clinical severity at diagnosis in 1705 patients with ulcerative colitis: a study by GISC (Italian Colon-Rectum Study Group). Dig Dis Sci 2000; 45: 462-5. DOI: 10. 1023/A: 1005424603085
12. Hadithi M, Cazemier M, Meijer GA, et al. Retrospective analysis of old-age colitis in the Dutch inflammatory bowel disease population. World J Gastroenterol 2008; 14: 3183-7. DOI: 10. 3748/wjg. 14. 3183
13. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19(Supl. A): 5A-36A.
14. Loftus EV Jr, Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: A systematic review. Aliment Pharmacol Ther 2002; 16: 51-60. DOI: 10. 1046/j. 1365-2036. 2002. 01140. x
15. Portela F, Magro F, Lago P, et al. Ulcerative colitis in a Southern European country: A national perspective. Inflamm Bowel Dis 2010; 16: 822-9. DOI: 10. 1002/ibd. 21119
16. Barreiro-de Acosta M, Magro F, Carpio D, et al. Ulcerative colitis in northern Portugal and Galicia in Spain. Inflamm Bowel Dis 2010; 16: 1227-38. DOI: 10. 1002/ibd. 21170
17. Solberg IC, Lygren I, Jahnsen J, et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol 2009; 44: 431-40. DOI: 10. 1080/00365520802600961
18. Dignass A, Eliakim R, Magro F, et al. Second European evidencebased consensus on the diagnosis and management of ulcerative colitis part 1: Definitions and diagnosis. J Crohns Colitis 2012; 6: 965-90. DOI: 10. 1016/j. crohns. 2012. 09. 003
19. Vind I, Riis L, Jess T, et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: A population-based study from the Danish Crohn colitis database. Am J Gastroenterol 2006; 101: 1274-82. DOI: 10. 1111/j. 1572-0241. 2006. 00552. x
20. Loftus CG, Loftus EV Jr, Harmsen WS, et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis 2007; 13: 254-61. DOI: 10. 1002/ibd. 20029
21. Ott C, Obermeier F, Thieler S, et al. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study. Eur J Gastroenterol Hepatol 2008; 20: 917-23. DOI: 10. 1097/MEG. 0b013e3282f97b33
22. Matsumoto S, Miyatani H, Yoshida Y. Ulcerative colitis: Comparison between elderly and young adult patients and between elderly patients with late-onset and long-standing disease. Dig Dis Sci 2013; 58: 1306-12. DOI: 10. 1007/s10620-012-2517-5
23. Charpentier C, Salleron J, Savoye G, et al. Natural history of elderlyonset inflammatory bowel disease: A population-based cohort study. Gut 2014; 63: 423-32. DOI: 10. 1136/gutjnl-2012-303864
24. Gower-Rousseau C, Dauchet L, Vernier-Massouille G, et al. The natural history of pediatric ulcerative colitis: A population-based cohort study. Am J Gastroenterol 2009; 104: 2080-8. DOI: 10. 1038/ajg. 2009. 177
25. Regueiro M, Kip KE, Cheung O, et al. Cigarette smoking and age at diagnosis of inflammatory bowel disease. Inflamm Bowel Dis 2005; 11: 42-7. DOI: 10. 1097/00054725-200501000-00006
26. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: Controversies, consensus, and implications. Gut 2006; 55: 749-53. DOI: 10. 1136/gut. 2005. 082909
27. Kalkan IH, Dagli U, Oztas E, et al. Comparison of demographic and clinical characteristics of patients with early vs. adult vs. late onset ulcerative colitis. Eur J Intern Med 2013; 24: 273-7. DOI: 10. 1016/j. ejim. 2012. 12. 014
28. Sarlos P, Kovesdi E, Magyari L, et al. Genetic update on inflammatory factors in ulcerative colitis: Review of the current literature. World J Gastrointest Pathophysiol 2014; 5: 304-21.
29. Ruel J, Ruane D, Mehandru S, et al. IBD across the age spectrum: Is it the same disease? Nat Rev Gastroenterol Hepatol 2014; 11: 88-98.
30. Mahid SS, Minor KS, Soto RE, et al. Smoking and inflammatory bowel disease: A meta-analysis. Mayo Clin Proc 2006; 81: 1462-71. DOI: 10. 4065/81. 11. 1462
31. Hoie O, Wolters F, Riis L, et al. Ulcerative colitis: Patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort. Am J Gastroenterol 2007; 102: 1692-701. DOI: 10. 1111/j. 1572-0241. 2007. 01265. x
32. Bringiotti R, Ierardi E, Lovero R, et al. Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease? World J Gastrointest Pathophysiol 2014; 5: 550-9.
33. Chen WX, Ren LH, Shi RH. Enteric microbiota leads to new therapeutic strategies for ulcerative colitis. World J Gastroenterol 2014; 20: 15657-63. DOI: 10. 3748/wjg. v20. i42. 15657
34. Quezada SM, Cross RK. Association of age at diagnosis and ulcerative colitis phenotype. Dig Dis Sci 2012; 57: 2402-7. DOI: 10. 1007/s10620-012-2081-z
35. Turner D, Levine A, Escher JC, et al. Management of pediatric ulcerative colitis: Joint ECCO and ESPGHAN evidence-based consensus guidelines. J Pediatr Gastroenterol Nutr 2012; 55: 340-61. DOI: 10. 1097/MPG. 0b013e3182662233
36. Dignass A, Lindsay JO, Sturm A, et al. Second European evidencebased consensus on the diagnosis and management of ulcerative colitis part 2: Current management. J Crohns Colitis 2012; 6: 991-1030. DOI: 10. 1016/j. crohns. 2012. 09. 002
37. Lakatos PL, David G, Pandur T, et al. IBD in the elderly population: Results from a population-based study in Western Hungary, 1977-2008. J Crohns Colitis 2011; 5: 5-13. DOI: 10. 1016/j. crohns. 2010. 08. 004